On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Dr Burnet received a BSc (Hons) in Biochemistry in 1985 from Hull University, an MSc in Neurochemistry from the Institute of Psychiatry, London, in 1986, and a PhD from Imperial College, London, in 1989. From 1989-1992, he was a post-doctoral Fogarty Visiting Fellow at the NIMH, USA, where he developed his interest in the neurobiology and treatment of psychiatric disorders. In 1992, Dr Burnet received an MRC Training Fellowship at the University Department of Psychiatry, Oxford, to study the neuropharmacology of antipsychotics drugs and the pathophysiology of schizophrenia. Dr Burnet is now an Associate Professor, and is currently investigating how the augmentation of gut microbial growth with prebiotics influences brain function.
